| Primary |
| Type 2 Diabetes Mellitus |
32.8% |
| Diabetes Mellitus |
22.4% |
| Hypertension |
16.5% |
| Depression |
5.1% |
| Hyperlipidaemia |
3.2% |
| Blood Cholesterol Increased |
2.0% |
| Coronary Artery Disease |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Neuropathy Peripheral |
1.9% |
| Angina Pectoris |
1.8% |
| Insomnia |
1.4% |
| Anxiety |
1.3% |
| Dyslipidaemia |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Diabetic Neuropathy |
1.0% |
| Drug Level |
1.0% |
| Hormone Replacement Therapy |
1.0% |
| Hypersensitivity |
1.0% |
| Angiopathy |
0.8% |
| Arteriosclerosis Coronary Artery |
0.8% |
|
| Weight Decreased |
19.0% |
| Vomiting |
13.1% |
| Hypoglycaemia |
9.8% |
| Pancreatitis |
7.2% |
| Pancreatitis Acute |
6.5% |
| Thyroid Neoplasm |
5.2% |
| Off Label Use |
4.6% |
| Pancreatic Carcinoma |
4.6% |
| Nausea |
3.3% |
| Renal Failure |
3.3% |
| Thyroid Cancer |
3.3% |
| Dermatitis Allergic |
2.6% |
| Erosive Oesophagitis |
2.6% |
| Myocardial Infarction |
2.6% |
| Pneumonia |
2.6% |
| Blood Glucose Increased |
2.0% |
| Cerebrovascular Accident |
2.0% |
| Choroid Melanoma |
2.0% |
| Drug Exposure During Pregnancy |
2.0% |
| Gallbladder Cancer |
2.0% |
|
| Secondary |
| Product Used For Unknown Indication |
30.8% |
| Type 2 Diabetes Mellitus |
28.5% |
| Hypertension |
10.4% |
| Diabetes Mellitus |
10.4% |
| Drug Use For Unknown Indication |
4.0% |
| Diabetes Mellitus Non-insulin-dependent |
2.5% |
| Blood Cholesterol Increased |
2.1% |
| Hyperlipidaemia |
1.4% |
| Hormone Replacement Therapy |
1.3% |
| Back Pain |
0.9% |
| Neuropathy Peripheral |
0.9% |
| Gastrooesophageal Reflux Disease |
0.8% |
| Hyperglycaemia |
0.8% |
| Blood Cholesterol |
0.7% |
| Blood Homocysteine Increased |
0.7% |
| Blood Pressure Increased |
0.7% |
| Diabetic Neuropathy |
0.7% |
| Insulin-requiring Type 2 Diabetes Mellitus |
0.7% |
| Depression |
0.7% |
| Food Craving |
0.7% |
|
| Weight Decreased |
26.5% |
| Vomiting |
10.0% |
| Malaise |
5.9% |
| Renal Failure Acute |
5.9% |
| Thyroid Cancer |
5.3% |
| Weight Increased |
5.3% |
| Off Label Use |
4.7% |
| Hypoglycaemia |
4.1% |
| Nausea |
4.1% |
| Renal Failure |
4.1% |
| Drug Exposure During Pregnancy |
2.9% |
| Gastrointestinal Disorder |
2.9% |
| Tubulointerstitial Nephritis |
2.9% |
| Dermatitis Allergic |
2.4% |
| Dyspepsia |
2.4% |
| Injection Site Haematoma |
2.4% |
| Medication Error |
2.4% |
| White Blood Cell Count Decreased |
2.4% |
| Body Mass Index Decreased |
1.8% |
| Diarrhoea |
1.8% |
|
| Concomitant |
| Type 2 Diabetes Mellitus |
28.5% |
| Product Used For Unknown Indication |
17.0% |
| Drug Use For Unknown Indication |
13.7% |
| Diabetes Mellitus |
10.7% |
| Hypertension |
7.3% |
| Hyperlipidaemia |
3.8% |
| Anxiety |
1.9% |
| Urinary Tract Infection |
1.9% |
| Blood Triglycerides Increased |
1.8% |
| Dry Eye |
1.7% |
| Rheumatoid Arthritis |
1.6% |
| Blood Cholesterol Increased |
1.5% |
| Diabetic Neuropathy |
1.5% |
| Depression |
1.3% |
| Insomnia |
1.3% |
| Atrial Fibrillation |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Neuropathy Peripheral |
1.0% |
| Osteoarthritis |
0.9% |
| Localised Infection |
0.8% |
|
| Weight Decreased |
25.6% |
| Nausea |
9.4% |
| Vomiting |
9.4% |
| Androgenetic Alopecia |
7.9% |
| Pericarditis |
6.9% |
| Weight Increased |
6.4% |
| Palpitations |
3.4% |
| Renal Impairment |
3.4% |
| Blood Glucose Increased |
3.0% |
| Pancreatitis |
3.0% |
| Urticaria |
3.0% |
| Orthostatic Hypotension |
2.5% |
| Pruritus |
2.5% |
| Alopecia |
2.0% |
| Headache |
2.0% |
| Malaise |
2.0% |
| Renal Haemorrhage |
2.0% |
| Stevens-johnson Syndrome |
2.0% |
| Treatment Failure |
2.0% |
| Tremor |
2.0% |
|
| Interacting |
| Product Used For Unknown Indication |
36.0% |
| Hypopituitarism |
24.0% |
| Type 2 Diabetes Mellitus |
12.0% |
| Insulin-requiring Type 2 Diabetes Mellitus |
8.0% |
| Atrial Fibrillation |
4.0% |
| Cerebrovascular Accident Prophylaxis |
4.0% |
| Diabetes Mellitus Inadequate Control |
4.0% |
| Onychomycosis |
4.0% |
| Tinea Infection |
4.0% |
|
| Drug Interaction |
25.0% |
| Hypoglycaemia |
25.0% |
| Drug Level Decreased |
16.7% |
| Malaise |
16.7% |
| Body Mass Index Decreased |
8.3% |
| Renal Failure Acute |
8.3% |
|
